Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease - Summary - MDSpire
Advertisement
Performance of ultrasound-guided attenuation parameter and 2D shear wave elastography in patients with metabolic dysfunction-associated steatotic liver disease
To assess the performance and reproducibility of ultrasound-guided attenuation parameter (UGAP) for quantifying hepatic steatosis and evaluate the performance of two-dimensional shear wave elastography (2D-SWE) for assessing hepatic fibrosis in patients with MASLD, highlighting the significance of these non-invasive techniques in improving patient management.
Key Findings:
UGAP demonstrated good-to-excellent performance for quantifying hepatic steatosis in patients with MASLD, with specific metrics of performance.
2D-SWE effectively assessed hepatic fibrosis in the same ultrasound examination.
Inter-operator and intra-operator reproducibility of UGAP measurements were confirmed.
Interpretation:
UGAP and 2D-SWE are promising non-invasive techniques for assessing hepatic steatosis and fibrosis in MASLD, potentially improving patient management by reducing reliance on invasive procedures.
Limitations:
Single-center study may limit generalizability.
Small sample size may affect the robustness of findings.
Potential biases or confounding factors that may affect the study results.
Conclusion:
UGAP and 2D-SWE are effective non-invasive tools for evaluating hepatic steatosis and fibrosis in MASLD, offering alternatives to invasive liver biopsy and emphasizing their importance in patient management.
